You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Tachosil: a new alternative for the treatment of non-traumatic corneal perforations
  1. M Hurtado-Sarrió1,
  2. A Duch-Samper2,
  3. A Cisneros-Lanuza1,
  4. M Díaz-Llopis1
  1. 1
    Ophthalmology Service, La Fe University Hospital, Valencia, Spain
  2. 2
    Ophthalmology Service, Arnau de Vilanova Hospital, Valencia, Spain
  1. Correspondence to Dr M Hurtado-Sarrió, Ophthalmology Service, La Fe University Hospital, Valencia, Spain, Esmeralda I, Casa 7, Mas Camarena, 46117 Betera, Valencia, Spain; hurtado_mer{at}gva.es

https://doi.org/10.1136/bjo.2009.158949

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    TachoSil is a collagen sponge with human fibrinogen 5.5 mg, and human thrombin 2.0 IU.

    Upon contact with physiological fluids or saline solution, the components of the coating dissolve and partly diffuse into the wound surface, creating a firm, mechanically stable network with good adhesive properties as well as sealing. Here we report the first case of the use of a collagen sponge combined with human fibrin sealant (TachoSil) in ophthalmology to patch a corneal perforation after infectious keratitis.

    Case report

    An 84-year-old Caucasian male with a history of heart disease treated with acenocoumarin and chronic obstructive pulmonary disease (COPD) reported to the emergency room with red eye, ocular pain, photophobia, decreased vision and discharge. At the slit-lamp examination, a large corneal stromal infiltrate with hypopyon was observed. A bacterial culture revealed Streptococcus pneumoniae. The keratitis responded to …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and Peer review Not commissioned; externally peer reviewed.

    • Ethics approval Ethics approval was provided by the Educational and Investigation Department of La Fe University Hospital, Valencia (Spain).

    • Patient consent Obtained.